|
ADMP
|
Adamis Pharmaceuticals Corporation
|
US
|
NASDAQ
|
|
REVB
|
Revelation Biosciences, Inc.
|
US
|
NASDAQ
|
|
RVNC
|
Revance Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AKBLF
|
ALK-Abelló A/S
|
US
|
OTC
|
|
HTSUF
|
Hisamitsu Pharm CO Ltd
|
US
|
OTC
|
|
MEDXF
|
Medexus Pharmaceuticals Inc
|
US
|
OTC
|
|
NPNKF
|
Nippon Shinyaku Co. Ltd
|
US
|
OTC
|
|
OPHLF
|
Ono Pharmaceutical
|
US
|
OTC
|
|
SNYNF
|
Sanofi
|
US
|
OTC
|
|
ALK-B
|
ALK-Abelló A/S
|
DK
|
CO
|
|
012790
|
Sinil Pharmaceutical Co. Ltd
|
KR
|
KQ
|
|
003000
|
Bukwang Pharm
|
KR
|
KO
|
|
214370
|
Caregen Co.Ltd
|
KR
|
KQ
|
|
BOI
|
Boiron SA
|
FR
|
PA
|
|
MARI
|
Marinomed Biotech AG
|
AT
|
VI
|
|
4AJ0
|
ALK-ABELLO AS DK -50
|
DE
|
F
|
|
93Z
|
MARINOMED BIOTECH AG INH.
|
DE
|
F
|
|
BON
|
Boiron SA
|
DE
|
F
|
|
CMH
|
Chordate Medical Holding AB
|
SE
|
ST
|
|
0OIR
|
ALK-Abello B
|
GB
|
LSE
|